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Abstract: 
 
Purpose: Essential fatty acids are critical for brain growth and neurodevelopment in infancy. 
Maternal diet and supplement use have a significant impact on the fat composition of human 
milk. The objective of this study is to assess supplement utilization patterns and fatty acid and 
brain-derived neurotrophic factor (BDNF) concentrations in the breast milk of women following 
vegan, vegetarian, and omnivore diet patterns. Methods: This is a cross-sectional, observational 
study of 74 lactating women in the United States following a vegan (n = 26), vegetarian (n = 22), 
or omnivore (n = 26) diet pattern. A single breast milk sample was collected from each 
participant and assessed for fatty acids and BDNF. Results: Median unsaturated fatty acids in 
the breast milk of vegan, vegetarian, and omnivores, as a percentage of total fatty acids, was 
66.0, 57.8, and 56.2%, respectively (p < 0.001). Total omega-3 percentages were 2.29% for 
vegans, 1.55% for vegetarians, and 1.46% for omnivores (p < 0.001). Docosahexaenoic acid 
percentages were not different by diet pattern, but over 80% of participants had milk 
concentrations below 0.30% of total fatty acids. Reports of omega-3 supplements use (10/74) 
and weekly seafood consumption (3/74) were limited. BDNF was not detectable in any samples. 
Conclusions: Breast milk from vegans had significantly higher unsaturated fat and total omega-3 
fats, and lower saturated fats, trans fats, and omega-6 to omega-3 ratios than their vegetarian and 
omnivore counterparts. Docosahexaenoic acid concentrations in breast milk were low regardless 
of maternal diet pattern, and were reflective of low seafood intake and supplement use. 
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Abbreviations 
 
ALA: Alpha-linolenic acid 
BDNF: Brain derived neurotrophic factor 
BSQ: Basic screening questionnaire 
DHA: Docosahexaenoic acid 
EPA: Eicosapentaenoic acid 
LA: Linoleic acid (LA) 
LCPUFA: Long chain polyunsaturated fatty acids 
 
Introduction 
 
The lipid fraction of human milk provides a major energy source for the rapidly growing infant 
as well as essential omega-3 and omega-6 polyunsaturated fatty acids which may be important 
for visual and neural development. On average, over 50% of calories in human milk comes from 
fat [1], although significant variation exists among lactating women, with total fat consistently 
being the most variable macronutrient [2,3,4,5,6]. Likewise, significant variability in omega-3 
and omega-6 fatty acid composition in human milk has been reported [7,8,9]. 
 
Alpha-linolenic acid (ALA), an essential omega-3 fatty acid, and linoleic acid (LA), an essential 
omega-6 fatty acid, are predominantly found in plant-based foods. The Recommended Dietary 
Allowance (RDA) for lactating women in the United States is 1.3 and 13.0 g/day for ALA and 
LA, respectively, though actual infant requirements are impacted by a complex set of factors 
including the kinetics of maternal dietary transfer into breast milk, maternal and infant stores, 
and endogenous synthesis of some nutrients. The long chain polyunsaturated fatty acids 
(LCPUFA) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) can be obtained 
primarily through fish-based foods or synthesized from ALA, though conversion rates are low, 
while arachidonic acid (AA) can be obtained from animal-based foods or derived from LA [10]. 
 
Reviews regarding the long-term effects of breastfeeding suggest a modest benefit to intelligence 
[11, 12]. There is considerable interest in the role of DHA as a potential mechanism for 
improved neurodevelopment due to evidence of higher DHA in the brain and plasma of breastfed 
infants compared to infants fed formula that was void of DHA [13,14,15]. Observational studies 
have shown a correlation between breast milk DHA levels and visual and neurodevelopment 
outcomes, though other components in human milk may be contributing to these observations 
[16]. In animal studies, dietary DHA was positively associated with brain-derived neurotrophic 
factor (BDNF), a growth factor that plays an important role in neurodevelopment [17,18,19]. In 
human studies, results on the relationship between dietary DHA and serum BDNF are conflicting 
[20, 21]. Nassar et al. reported higher levels of serum BDNF in breastfed infants, compared to 
formula fed infants, though breast milk was not measured as a potential source of the BDNF 
[22]. Limited studies have assessed BDNF in human milk, with a 100-fold difference in 
concentrations reported between studies [23,24,25]. No studies have investigated a potential 
relationship between BDNF concentrations in human milk and maternal diet. 
 
Maternal diet has a strong influence on the lipid profile of human milk [26,27,28]. Vegetarian 
and vegan diets provide differing content of total, saturated, unsaturated, and essential fats 
compared to omnivore diet patterns [29, 30], which likely influences breast milk composition. 
Conflicting findings regarding the LCPUFA content in human milk of women who followed a 
plant-based diet have been reported [31,32,33]. DHA supplements, but not ALA supplements, 
have been shown to increase breast milk DHA concentrations [34,35,36,37,38], which may be an 
important strategy for lactating women who consume little dietary DHA. 
 
The purpose of this study is to assess DHA supplement utilization patterns, and fatty acid and 
BDNF concentrations in the breast milk of healthy, lactating women in the United States who 
follow three different diet patterns: vegan, vegetarian, and omnivore. We hypothesize that there 
will be significant differences in BDNF and fatty acid profiles between diet groups, and that 
DHA supplement use and fish intake will predict breast milk DHA concentrations. 
 
Methods 
 
Subject recruitment 
 
This was a cross-sectional, observational study of lactating women in the United States who 
were recruited between November 2016 and April 2017 through online communities focused on 
breastfeeding or vegetarianism, and through local religious communities with a vegetarian 
population. Inclusion criteria were: maternal age of 18 or older; stage of lactation 2 weeks or 
more postpartum; healthy, term birth; willingness to provide one breast milk sample for the study 
and complete a short diet survey. Exclusion criteria included any of the following conditions: 
pregnant; taking metformin; Crohn’s disease; Celiac disease; MTHFR gene mutation; liver 
disease; myeloproliferative disorders; hyperthyroid or hypothyroid. Interested individuals were 
asked to complete an online basic screening questionnaire (BSQ) to determine eligibility and 
self-identify their diet pattern (vegan, vegetarian, omnivore). The BSQ was completed by 371 
individuals, 229 were excluded because they did not qualify or because target sample size had 
been reached, 142 were invited to participate, and 74 completed the study. This study was part of 
a project to assess vitamin B12 composition in human milk, with sample size calculations, and 
B12 results reported elsewhere [39]. Briefly, over 90% of vegans reported using supplements 
containing B12 and there was no observed difference in the breast milk B12 concentrations by 
maternal diet pattern. Subjects were provided with a digital informed consent and received a $25 
gift card for participation. This study was approved by the Institutional Review Boards at East 
Carolina University and the University of North Carolina at Greensboro. 
 
Diet survey and sample collection 
 
Participants were asked to complete a digital questionnaire which included demographic, diet, 
and supplement information. Consumption of meat (beef, lamb, pork, and poultry), dairy (milk, 
cheeses, and yogurts), egg, fish, and omega-3 supplemented margarine were categorized as 
follows: Never; Rarely (less than 1 times per month); Sometimes (1–4 times per month), Often 
(more than 1 time per week). A diet category was assigned to each participant based on detailed 
responses to the diet survey as follows: vegans never consumed meat and never or rarely 
consumed other animal products; vegetarians never or rarely consumed meat and sometimes or 
often consumed other animal products; omnivores consumed meat sometimes or often. To ensure 
a representative milk sample was collected, participants received written collection instructions. 
Briefly, samples were collected in the morning during the first or second feeding of the day, and 
at least 2 h since the previous feeding, by complete expression of one breast in a dimly lit room, 
to help protect light-sensitive nutrients [40]. The entire sample was transferred to a storage 
container appropriate for breast milk storage, dated, wrapped in aluminum foil, and placed in the 
freezer until the sample was collected by a researcher, or shipped on dry ice to the University of 
North Carolina Greensboro laboratory. Upon receipt, samples were thawed, gently mixed by 
hand, and aliquoted in a dimly lit lab, and stored at − 20 °C until analysis. Total storage time of 
samples (at subject’s home and in the lab) averaged 197 days (minimum 93 days; maximum 257 
days) prior to completion of fatty acid and BDNF analysis. Average total storage time prior to 
creamatocrit analysis was 340 days (minimum 236 days; maximum 400 days). 
 
Milk analysis 
 
Total fat was measured by creamatocrit, using previously described methods for human milk that 
were validated against reference methods [41]. Briefly, samples were thawed, vortexed for 10 s, 
and drawn into a 75 µL capillary tube which was centrifuged at 11,200 RPM for 12 min on a 
Zip-IQ PCV flatbed centrifuge (LW Scientific, Lawrenceville, GA). Capillary tubes were 
immediately read on a Creamatocrit Plus (EKF Diagnostics, Boerne, TX) by a trained researcher. 
Samples were measured in duplicate and the average coefficient of variation (CV) was 2.3%. 
 
The fatty acids present in the samples were measured as fatty acid methyl esters according to the 
method of Bannon et al. [42]. Briefly, 0.2 g of milk was hydrolyzed using 1.0 mL of 0.5 N 
methanolic sodium hydroxide (Thermo Fisher Scientific, Fair Lawn, NJ) for 5 min. The resulting 
fatty acids were converted to their methyl esters by the addition of 1.0 mL of boron trifluoride 
(Sigma Chemical Corp., St. Louis, MO) as a catalyst and refluxing for an additional 10 min. The 
methyl esters were extracted into 1.0 mL of hexane. The resulting fatty acid methyl esters were 
analyzed using a Perkin Elmer Autosampler XL GC (Perkin Elmer Instruments, Norwalk, CN) 
and a BPX-70 column (SGE Analytical Science, Austin, TX) with a flame ionization detector 
(FID) and a capillary column containing 70% cyanopropyl polysilphenylene-siloxane as the 
stationary phase (30 m length, 0.25 mm i.d., 0.25 mm film thickness). Helium was used as the 
carrier gas at 1.85 mL/min. A temperature program was used with an initial temperature of 60 °C 
held for 2 min. The temperature was increased to 180 °C at 10°C/min, then to a final temperature 
of 235 °C at 4°C/min. The injector was heated to 265 °C and the split flow was 76.9 mL/min. 
The detector temperature was 265 °C. Fatty acids were identified by comparison with fatty acid 
methyl ester standards purchased from Matreya (Matreya, Inc., Pleasant Gap, PA). The amount 
of each fatty acid present was calculated by normalizing the peak area for each fatty acid 
identified against the total peak area according to AOCS Method Ce 1b-89 [43]. Fatty acid 
composition is reported as g/100 g total fatty acids and is detectable to 0.01 g per 100 g of total 
fatty acids. Values that fell below the limit of detection were set to zero. Duplicate readings were 
performed on 33 of the samples and the average CV was 7.6%. 
 
Total BDNF was measured in duplicate using a Quantikine Total BDNF ELISA kit (part number 
DBNT00, R&D Systems, Minneapolis, MN) which has a standard curve range of 15.6–
1000 pg/mL. This method was selected because it was used in two of the three published studies 
on BDNF in human milk, and was the only published methods available at the time that had been 
validated by the manufacturer for use with human milk [23, 25]. Samples were prepared 
according to the manufacturer’s instructions to centrifuge for 15 min at 1000 RPM, remove the 
aqueous fraction, and repeat two more times. Alternative sample preparation methods were also 
used based on those reported by others including centrifuging at increased speeds of 10,000 
RPM and acidification to potentially improve BDNF binding capacity [23, 25, 44]. The average 
CV for duplicate samples read on a BioTek Synergy Plate Reader (BioTek Instruments, 
Winooski, VT) at 450 nm was 1.8% and the average R2 value for the standard curves was 0.999. 
 
Statistical analysis 
 
Descriptive statistics were computed for all outcome variables. Distribution of data for normalcy 
was evaluated using a Shapiro–Wilk test. Normally distributed outcome variables were evaluated 
using a one-way ANOVA. Distributions of non-parametric variables were evaluated using a 
Kruskal–Wallis test. Due to the large number of statistical tests performed on numerical outcome 
variables, a Bonferroni correction to the p value was computed as 0.05/41 which resulted in a 
significance threshold of 0.001. Differences in categorical variables were evaluated using a 
Fisher’s exact test with a significance threshold of 0.05. Linear regression was used to identify 
other significant predictor variables including maternal age, parity, BMI, and stage of lactation. 
Analysis was conducted using SAS Enterprise Software 9.4 (SAS Corporation; Cary, NC). 
 
Results 
 
A total of 74 participants completed this study, with 26 classified as vegan, 22 classified as 
vegetarian, and 26 classified as omnivores based on responses to the diet survey. There was no 
significant difference in age, parity, ethnicity, or education (p > 0.05), but maternal BMI and 
lactation stage differed (p < 0.05) by diet type. Ten participants (13.5%) reported using 
DHA/EPA supplements, with differences in supplement use by diet pattern approaching 
significance (vegan 26.9%; vegetarian 9.1%; omnivore 3.9%; p = 0.052). There was a significant 
difference in the frequency of consumption of meat, dairy, eggs, and fish by diet group 
(p < 0.001). Consumption patterns of omega-3 containing margarines did not differ by group. 
Descriptive statistics of study participants and their diet patterns are summarized in Table 1. 
 
Table 1. Summary of study participants and dietary habits 
  Vegan (n = 26) Vegetarian (n = 22) Omnivores (n = 26) p value 
Maternal age (years) 32.7 (5.2) 32.2 (4.6) 31.0 (4.7) 0.438 
Maternal parity (births) 1.8 (0.8) 1.6 (0.8) 2.3 (1.8) 0.158 
Maternal BMI (kg/m2) 22.8a (3.1) 23.9ab (3.8) 25.8b (4.5) 0.021 
Lactation stage (weeks) 36.6ab (27.7) 54.6a (46.0) 27.5b (19.8) 0.017 
Diet duration (years) 6.2a (5.5) 7.5a (5.55) 25.8b (11.5) < 0.001 
Ethnicity: # (%)    0.900 
 Black 0 (0.0) 0 (0.0) 0 (0.0)  
 Asian 1 (3.9) 0 (0.0) 0 (0.0)  
 Hispanic 1 (3.9) 1 (4.6) 1 (3.9)  
 White 22 (84.6) 20 (90.9) 21 (80.8)  
 Mixed/other 2 (7.7) 1 (4.6) 4 (15.4)  
Education    0.279 
 HS/GED/other 1 (3.9) 0 (0.0) 1 (3.9)  
 Some college/technical 2 (7.7) 3 (13.6) 7 (26.9)  
 4-year college degree 8 (30.8) 11 (50.0) 9 (34.6)  
 Graduate degree 15 (57.7) 8 (36.4) 9 (34.6)  
  Vegan (n = 26) Vegetarian (n = 22) Omnivores (n = 26) p value 
Food consumption patterns: # (%)     
 Meat products    < 0.001 
  Never 26 (100.0) 18 (81.8) 0 (0.0)  
  Rarely 0 (0.0) 4 (18.2) 0 (0.0)  
  Sometimes 0 (0.0) 0 (0.0) 3 (11.5)  
  Often 0 (0.0) 0 (0.0) 23 (88.5)  
 Dairy products    < 0.001 
  Never 23 (88.5) 1 (4.6) 0 (0.0)  
  Rarely 3 (11.5) 1 (4.6) 1 (3.9)  
  Sometimes 0 (0.0) 5 (22.7) 0 (0.0)  
  Often 0 (0.0) 15 (68.2) 25 (95.2)  
 Eggs    < 0.001 
  Never 25 (96.2) 4 (18.2) 0 (0.0)  
  Rarely 1 (3.9) 3 (13.6) 1 (3.9)  
  Sometimes 0 (0.0) 6 (27.3) 8 (30.8)  
  Often 0 (0.0) 9 (40.9) 17 (65.4)  
 Fish    < 0.001 
  Never 26 (100.0) 18 (81.8) 1 (3.9)  
  Rarely 0 (0.0) 1 (4.6) 10 (38.5)  
  Sometimes 0 (0.0) 3 (13.6) 12 (46.2)  
  Often 0 (0.0) 0 (0.0) 3 (11.5)  
 Omega-3 margarine    1.00 
  Never 23 (88.5) 20 (90.9) 22 (84.6)  
  Rarely 2 (7.7) 1 (4.6) 2 (7.7)  
  Sometimes 1 (3.9) 1 (4.6) 1 (3.9)  
  Often 0 (0.0) 0 (0.0) 1 (3.9)  
Use DHA/EPA supplement: # (%) 7 (26.9) 2 (9.1) 1 (3.9) 0.052 
Numerical data are presented as means (standard deviations) and are evaluated with one-way ANOVA and Tukey 
HSD for multiple comparisons. Values in the same row with a common letter in the superscript are not significantly 
different. Categorical data are presented as # (%) and are evaluated using Fisher’s exact test. Food frequency 
definitions: never; rarely (less than 1 times per month); sometimes (1–4 times per month), often (more than 1 time 
per week) 
 
Fat content in human milk by diet pattern 
 
Thirty-one of the 41 outcome variables measured followed a non-parametric distribution; 
therefore, median and interquartile descriptive statistics are provided in Table 2 by maternal diet 
pattern. There was a significant difference (p ≤ 0.001) in the breast milk composition of saturated 
fat, unsaturated fat, and trans fats by diet. Long chain fatty acids containing 15 or more carbons 
were the predominant fatty acids in all samples (mean = 84.3%; min = 61.3%; max = 91.3%), and 
no differences in the distribution of total long chain (p = 0.906) or total medium chain (p = 0.897) 
fatty acids between diet groups were observed. Nine fatty acids made up 93% or more of the 
fatty acids in all milk samples, regardless of maternal diet: C10:0; C12:0; C14:0; C16:0; 
C16:1,cis; C18:0; C18:1,cis; C18:2,cis n-6; and C18:3,cis n-3. Of these most abundant fatty 
acids, five of them were significantly different by diet group: C16:0; C16:1,cis; C18:0; 
C18:1,cis; and C18:3,cis n-3 (p ≤ 0.001). Fatty acids that were present in smaller quantities were 
also significantly different by diet group. 
 
Table 2. Fat composition of human milk by maternal diet pattern 
  Vegan (n = 26) Vegetarian (n = 22) Omnivores (n = 26) *p value 
Total fat (g/dL) 3.0 (1.7) 4.0 (2.9) 4.0 (2.9) 0.041 
 % Saturated* 33.1 (6.2) 40.0 (8.6) 42.3 (8.4) < 0.001 
  C8:0 0.21 (0.13) 0.18 (0.15) 0.17 (0.18) 0.052 
  C10:0 1.46 (0.71) 1.50 (0.74) 1.65 (0.43) 0.332 
  C12:0 7.12 (3.63) 5.88 (2.01) 6.22 (3.07) 0.186 
  C14:0 5.55 (3.89) 6.81 (3.06) 6.56 (3.36) 0.571 
  C15:0* 0.06 (0.08) 0.24 (0.20) 0.26 (0.16) < 0.001 
  C16:0* 13.32 (2.49) 18.57 (5.22) 20.02 (4.43) < 0.001 
  C17:0* 0.12 (0.02) 0.22 (0.11) 0.26 (0.07) < 0.001 
  C18:0* 3.98 (1.27) 5.85 (2.52) 6.12 (1.72) < 0.001 
  C20:0 0.16 (0.14) 0.20 (0.16) 0.09 (0.15) 0.002 
  C22:0 0.06 (0.09) 0.05 (0.08) 0.00 (0.04) 0.015 
  C24:0 0.00 (0.07) 0.06 (0.08) 0.00 (0.08) 0.765 
 % Unsaturated* 66.0 (6.5) 57.8 (9.8) 56.2 (8.5) < 0.001 
  Total omega-3* 2.29 (0.77) 1.55 (0.56) 1.46 (0.94) < 0.001 
    ALA (C18:3 cis)* 2.09 (0.75) 1.40 (0.70) 1.19 (0.80) < 0.001 
    EPA (C20:5 cis) 0.0 (0.05) 0.0 (0.05) 0.04 (0.18) 0.057 
    DHA (C22:6 cis) 0.14 (0.09) 0.17 (0.14) 0.18 (0.18) 0.543 
  Total omega-6 19.65 (2.88) 18.69 (6.76) 17.11 (6.39) 0.492 
    LA (C18:2cis) 18.86 (2.29) 17.98 (6.91) 16.28 (6.40) 0.366 
    C18:3 cis, gamma* 0.0 (0.0) 0.0 (0.15) 0.08 (0.19) < 0.001 
    C20:3 cis 0.27 (0.09) 0.34 (0.11) 0.31 (0.13) 0.106 
   AA (C20:4) 0.38 (0.21) 0.38 (0.13) 0.45 (0.16) 0.014 
  LA : ALA* 9.3 (2.1) 12.2 (4.9) 12.7 (6.2) < 0.001 
  Omega-6: omega-3* 8.8 (2.4) 11.4 (3.7) 11.2 (3.8) < 0.001 
  C14:1 cis* 0.00 (0.07) 0.20 (0.13) 0.23 (0.15) < 0.001 
  C15:1 cis 0.00 (0.00) 0.00 (0.05) 0.00 (0.04) 0.002 
  C16:1 cis 9* 1.01 (0.89) 1.44 (0.86) 2.04 (0.63) < 0.001 
  C17:1 cis* 0.03 (0.08) 0.12 (0.09) 0.16 (0.06) < 0.001 
  C18:1cis* 39.86 (7.56) 35.09 (7.96) 33.09 (8.50) < 0.001 
  C20:1 cis 0.38 (0.16) 0.33 (0.10) 0.29 (0.12) 0.003 
  C20:2 cis 0.26 (0.15) 0.26 (0.08) 0.27 (0.11) 0.873 
  C22:1 cis 0.00 (0.09) 0.05 (0.07) 0.00 (0.05) 0.278 
  C24:1 cis 0.00 (0.01) 0.00 (0.03) 0.00 (0.0) 0.430 
 % Total Trans* 0.44 (0.19) 0.66 (0.71) 1.09 (0.55) < 0.001 
  C14:1 trans 0.00 (0.00) 0.00 (0.03) 0.00 (0.00) 0.108 
  C16:1trans 0.36 (0.17) 0.34 (0.10) 0.36 (0.10) 0.863 
  C18:1 trans* 0.00 (0.07) 0.14 (0.61) 0.62 (0.45) < 0.001 
  C18:2 trans 0.00 (0.07) 0.14 (0.34) 0.15 (0.29) 0.021 
 Medium chain (%) 14.9 (6.3) 14.6 (5.6) 14.9 (6.7) 0.897 
 Long chain (%) 85.1 (6.9) 85.4 (5.9) 85.6 (6.7) 0.906 
Data represent median (interquartile range, computed as quartile 3 subtract quartile 1). Bold font indicates outcome 
variables that followed a normal distribution and mean differences were evaluated using a one-way ANOVA; 
regular font indicates outcome variables that followed a non-parametric distribution and distributions were evaluated 
using a Kruskal–Wallis test 
*The p value for significance was determined using a Bonferroni’s correction of 0.05/41 (p ≤ 0.001) 
 
Omega-3, omega-6, and BDNF 
 
The omega-3 fatty acids measured included ALA, EPA, and DHA. DHA was undetectable in 
11/74 (14.9%) samples and EPA was undetectable in 39/74 (52.7%) samples, with no observed 
difference in prevalence of undetectable samples by diet groups (p > 0.05). A significant 
difference in total omega-3 fatty acids was observed by diet group, driven by higher percentages 
of ALA (p ≤ 0.001), but not EPA (p = 0.057) or DHA (p = 0.543). Eighty-two percent (61/74) of 
study participants had DHA milk concentrations below 0.3%, and there was no difference in the 
prevalence of low milk DHA (< 0.3%) by diet group (p = 0.555). 
 
The omega-6 fatty acids measured included LA, gamma linolenic acid (C18:3,cis,gamma), 
dihomo-gamma linolenic acid (C20:3,cis), and AA. No difference in total omega-6 fatty acids 
was observed by diet pattern, but there were significant differences in gamma linolenic acid 
(p ≤ 0.001). The ratio of LA to ALA (median, IQR) was significantly lower (p ≤ 0.001) in the 
breast milk of vegans (9.3, 2.1) compared to vegetarians (12.2, 4.9) and omnivores (12.7, 6.2). 
When excluding the 10 participants who reported taking DHA/EPA supplements from the 
analysis, there were no changes to the significant findings related to omega-3 fatty acids. Use of 
a DHA/EPA supplement was a significant positive predictor of milk ALA, DHA, and total 
omega-3 composition, and a significant negative predictor of omega-6:omega-3 ratios (Table 3). 
There was no measurable BDNF in any samples. 
 
Table 3. Bivariate regression analysis of significant maternal factors predicting human milk fat 
composition 
  β Standard error Standardized β Adjusted R2 p value 
Use of DHA/EPA supplement      
 DHA 0.10 0.040 0.277 0.064 0.017 
 Total omega-3 0.71 0.196 0.392 0.142 < 0.001 
 Omega-6:omega-3 ratio − 2.84 0.986 − 0.321 0.091 0.005 
 C18:3,cis (ALA) 0.62 0.194 0.352 0.112 0.002 
Stage of lactation      
 C14:0 0.03 0.009 0.398 0.147 < 0.001 
 C16:1,cis − 0.01 0.002 − 0.353 0.112 0.002 
 Medium chain FFA 0.04 0.020 0.228 0.039 0.050 
 Long chain FFA − 0.04 0.020 − 0.239 0.044 0.041 
Maternal BMI      
 C16:0 0.31 0.119 0.291 0.072 0.012 
 C16:1,cis 0.05 0.018 0.286 0.069 0.014 
 C18:1,cis − 0.37 0.177 − 0.241 0.045 0.038 
Maternal age      
 Total fat 0.10 0.047 0.245 0.047 0.036 
 C8:0 0.01 0.00 0.365 0.121 0.001 
 C20:5 (EPA) − 0.01 0.00 − 0.305 0.080 0.008 
 
Other factors predicting human milk fat profiles 
 
Stage of lactation, maternal BMI, and maternal Age were modeled against individual fatty acids, 
and fat subcategories (total, saturated, unsaturated, trans, medium chain, long chain, omega-3, 
and omega-6) to evaluate other potential relationships in our dataset. A summary 
of β coefficients, and R square values are presented in Table 3 for variables with a significant 
relationship. 
 
Discussion 
 
Polyunsaturated fatty acids 
 
We observed a significant difference in the saturated, unsaturated, and omega-3 fatty acid 
profiles of breast milk from lactating women by maternal diet pattern. This supports our 
hypothesis that maternal plant-based diets, which are rich in unsaturated fats, have a significant 
impact on breast milk lipid profiles; however, within the family of omega-3 fatty acids we did 
not observe a difference in DHA, which was unexpected. There are conflicting findings in the 
literature regarding the impact of maternal plant-based diets on DHA composition of breast milk 
from women living in the United States. Two small studies reported no difference in breast milk 
DHA between vegetarians and omnivores, but both studies were small, and occasional fish 
consumption in one vegetarian group may have influenced findings [31, 32]. Sanders et al. 
studied the breast milk of 19 vegans, 5 vegetarians, and 21 omnivores and reported DHA 
composition of 0.14, 0.30, and 0.37%, respectively, which was significantly different by diet 
[33]. While we did not observe differences in DHA by diet type, it is important to note that the 
median DHA composition across all diet groups in our study was much lower than those 
reported by Sanders et al. and compared to worldwide averages [8, 9, 33]. We observed median 
DHA of 0.14, 0.17, and 0.18% for vegans, vegetarians, and omnivores, respectively. Two 
independent reviews of worldwide DHA breast milk concentrations reported averages of 0.32–
0.37%, with concentrations in US populations often reported at 0.20% or lower, which is similar 
to our findings [8, 9]. While use of a DHA supplement is well supported in the literature as a 
way to increase breast milk DHA [34,35,36,37,38], less than one-third of vegans in our study 
reported using DHA supplements. Similarly, fish consumption was low, with only 3/26 (11.5%) 
of omnivores and 0/22 (0.0%) vegetarians reporting more than weekly consumption. This 
suggests low adherence to recommendations in the 2015 Dietary Guidelines for Americans 
(DGAs) for seafood consumption of eight ounces per week [45]. A recent study on seafood 
consumption patterns in the United States reported over 80% of Americans were not meeting 
DGA seafood recommendations, which is consistent with our observation of limited seafood 
intake, even among omnivores [46]. 
 
There is limited research on infant outcomes related to breast milk lipid composition. 
Observational studies have shown a relationship between breast milk DHA and infant visual and 
neurodevelopment outcomes [14, 16]. A recent review by Innis suggested that infant DHA 
biomarkers are likely influenced by many factors including maternal DHA status during 
pregnancy, breast milk DHA concentration, and genetic differences in DHA synthesis pathways 
[16]. Intervention studies of DHA supplementation among lactating women have reported 
inconclusive findings, which may be attributed to a wide range of supplement doses and varying 
baseline DHA levels [16, 47, 48]. While there is currently no RDA for DHA, several researchers 
have recommended establishing an RDA of 200 mg/day of DHA during pregnancy and lactation 
which would yield breast milk DHA of 0.30% [47, 49, 50]. Eighty-two percent of our study 
participants had breast milk DHA concentrations below 0.30%, suggesting potential widespread 
inadequacy of breast milk DHA levels in lactating women in the United States, independent of 
maternal diet pattern. 
 
Trans fats 
 
In 2015, the Food and Drug Administration (FDA) removed the “generally regarded as safe” 
designation from trans fats due to growing evidence of health risks [51]. Studies conducted prior 
to this ruling suggest that trans fats were present in breast milk, with reported averages of 7% 
[52, 53]. Friesen et al. documented a decline in breast milk trans fats between 2004 (mean 6.2%) 
and 2006 (mean 4.6%) in Canadian women after changes in trans fat food labeling requirements 
went into effect [54]. In our study, median trans fat breast milk concentrations were below 1.1%, 
with vegans having lower levels than vegetarians and omnivores. Our findings of overall low 
breast milk trans fat composition is supported by evidence that trans fat intake declined steadily 
in the United States between 1999 and 2010 [55]. 
 
Brain derived neurotrophic factor 
 
Using an assay validated for human milk, we found that BDNF was not detectable in any of our 
samples, which is inconsistent with the findings of others who used the same commercial ELISA 
[23, 25]. Li et al. measured BDNF in the breast milk of 42 healthy Chinese women at 3, 10, and 
30 days postpartum and reported average BDNF levels of 10–13 pg/mL, which is below the 
standard curve range of 15.6–1000 pg/mL [23]. Protein levels of human milk drop significantly 
in the first weeks postpartum, which may explain differences in findings, since our study 
excluded participants from the early postpartum period. Alternatively, our samples generated low 
levels of BDNF similar to Li et al., prior to deducting absorption values of a blank on the 96-well 
plate; therefore, calculation methods may also explain differences in reported results. Ismail et al. 
studied BDNF in the breast milk of 30 women with epileptic infants and 15 healthy controls and 
reported significantly higher breast milk BDNF concentrations (min–max) in the mothers of 
epileptic infants (1285–2077 pg/mL) compared to controls (585–995 pg/mL) [25]. While breast 
milk DHA was not reported in either of these studies, it is important to note that these studies 
were conducted in Egypt and China, where DHA intake may have differed from our study 
population. Dangat et al. used a different ELISA kit not specifically identified for use with 
human milk and reported breast milk BDNF concentrations in the range of 300 pg/mL, with 
significant differences between women with preeclampsia and healthy controls [24, 56]. Breast 
milk DHA concentrations were also reported and were significantly higher in women with 
preeclampsia, though mean concentrations in both groups were well below the worldwide 
average of 0.30% [56]. Both Li and Ismail reported centrifuging samples at speeds higher than 
those provided in the manufacturer’s instruction while Dangat did not describe sample 
preparation protocols. Our lab tried a variety of published sample preparation techniques 
including using increased centrifuge speed and sample acidification and did not find measurable 
BDNF in any samples when adjusting for the absorption readings of a blank. The ELISA 
manufacturer reported average recovery of 94% in human milk samples spiked with BDNF, and 
that BDNF was undetectable in the breast milk of 10 healthy volunteers, which is in alignment 
with our findings. The 100-fold difference in breast milk BDNF composition reported in the 
literature suggests that more research is needed in understanding the potential presence and role 
of BDNF in human milk and its association with maternal DHA intake. Detailed descriptions of 
sample preparation protocols are important for comparing results across multiple studies given 
the inconsistencies in the literature. 
 
Limitations 
 
Study recruitment was conducted primarily online and represents a convenience sample with 
limited ethnic or educational diversity; therefore, study findings may not reflect nutritional status 
of other populations consuming low animal-product diets (e.g., food insecure). This was a cross 
sectional analysis, with differences in maternal BMI, stage of lactation, and supplement use 
between diet groups; however, neither maternal BMI nor stage of lactation were significant 
predictors of total unsaturated fat, trans fat, or omega-3 fatty acid composition. Because this was 
a cross-sectional study with only one sample collected per subject, we were not able to assess 
how fatty acid profiles of human milk change within a subject who follows a defined diet 
pattern. The sample size for this study was based on detecting differences in B12 concentration 
of human milk and may not have been adequate to detect differences in all fatty acids assessed, 
though several significant differences were observed. 
 
Conclusions 
 
In this cross-sectional study of human milk from women following three distinct dietary patterns, 
we observed significant differences in breast milk from vegan women compared to vegetarian 
and omnivores, including higher unsaturated fat, total omega-3 fats, and ALA, and lower 
saturated fats, trans fats, and ALA to LA ratios. There was no difference in milk DHA 
composition by diet group, but over 80% of study participants had milk concentrations below the 
0.30% target suggested by expert committees. Supplement use was associated with higher breast 
milk DHA composition, which may be an important strategy for lactating women who consume 
low dietary DHA to ensure an adequate DHA supply for the breastfeeding infant. BDNF was not 
detectable in the breast milk of any participants, which conflicts with the findings of others. 
More research is needed to understand the relationship between maternal DHA status during 
pregnancy, breast milk DHA and BDNF concentrations, and the role of DHA supplementation in 
lactating women as it relates to infant outcomes. 
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